Tirzepatide
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURM
Eli Lilly · Phase 3 · Recruiting · Enrollment 150
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Tirzepatide | Obesity or overweight | n/r | 104 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 104 | n/r | n/r |